Traumeric
Traumeric by Ortho Molecular Products is an 'Other Combinations' supplement, commonly used for its potential anti-inflammatory properties, falling under the Longevity & NAD+ category. It features a blend of 5 ingredients, including 660 mg of Turmeric root extract, 240 mg of Bromelain, 240 mg of Quercetin Dihydrate, 50 mg of Rutin, and 30 mg of Vitamin C. The product received an N+ Score of 46, earning an F grade, placing it in the below-average tier. While it contains several ingredients often associated with anti-inflammatory research, the Vitamin C dosage at 30 mg is underdosed compared to typical clinical recommendations for standalone supplementation. None of the ingredients are noted to be at clinically effective dosages within this specific formulation. This product may be considered by individuals exploring natural anti-inflammatory support, but specific ingredient dosages should be reviewed.
About This Product
Traumeric by Ortho Molecular Products is a longevity & nad+ supplement containing 5 active ingredients. It has earned an N+ Score of 46/100 (Grade F).
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
Weaknesses
- −Several ingredients below clinically effective doses
- −Missing several expected ingredients for its category
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Vitamin C | 30.000 mg | Under |
| Bromelain | 240.000 mg | N/A |
| Quercetin Dihydrate | 240.000 mg | N/A |
| Rutin | 50.000 mg | N/A |
| Turmeric root extract | 660.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.





